| Bioactivity | Methyl 6-amino-9-β-D-ribofuranosyl-9H-purine-2-carboxylate is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | Methyl 6-amino-9-β-D-ribofuranosyl-9H-purine-2-carboxylate |
| CAS | 70255-70-8 |
| Formula | C12H15N5O6 |
| Molar Mass | 325.28 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
Methyl 6-amino-9-β-D-ribofuranosyl-9H-purine-2-carboxylate
CAS: 70255-70-8 F: C12H15N5O6 W: 325.28
Methyl 6-amino-9-β-D-ribofuranosyl-9H-purine-2-carboxylate is a purine nucleoside analogue. Purine nucleoside analogs h
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.